| Authors: |
Papadopoulos KP; START Center for Cancer Research, San Antonio, TX, USA. Electronic address: Kyri.Papadopoulos@startresearch.com., Sharma MR; START Center for Cancer Research - Midwest, Grand Rapids, MI, USA., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Colombo I; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Ramelyte E; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Seamon L; START Center for Cancer Research - Midwest, Grand Rapids, MI, USA., Rasco DW; START Center for Cancer Research, San Antonio, TX, USA., Rodriguez-Freixinos V; Debiopharm International SA, Lausanne, Switzerland., Dozio V; Debiopharm International SA, Lausanne, Switzerland., Tat T; Debiopharm International SA, Lausanne, Switzerland., Luong N; Debiopharm International SA, Lausanne, Switzerland., Mathon C; Debiopharm International SA, Lausanne, Switzerland., Fuchs J; Debiopharm International SA, Lausanne, Switzerland., Massiere F; Debiopharm International SA, Lausanne, Switzerland., Hurynovich A; Debiopharm International SA, Lausanne, Switzerland., Omar M; Debiopharm International SA, Lausanne, Switzerland., Micallef S; Debiopharm International SA, Lausanne, Switzerland., Bellon A; Debiopharm International SA, Lausanne, Switzerland., Rodrigo Imedio E; Debiopharm International SA, Lausanne, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland. |
